|
|
Volumn 7, Issue SUPPL.1, 2012, Pages
|
|
Presently available biosimilars in hematology-oncology: G-CSF
a
|
|
Author keywords
Biograstim; Biosimilars G CSF; Nivestim; Ratiograstim; Tevagrastim; Zarzio
|
|
Indexed keywords
BIOSIMILAR AGENT;
GRANULOCYTE COLONY STIMULATING FACTOR;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
UNCLASSIFIED DRUG;
XM 02;
ABDOMINAL PAIN;
ALOPECIA;
ASTHENIA;
BIOTECHNOLOGY;
BONE PAIN;
COMPARATIVE STUDY;
DIARRHEA;
DRUG APPROVAL;
DRUG DOSAGE FORM COMPARISON;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG INDICATION;
DRUG MANUFACTURE;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
EUROPE;
HEMATOLOGY;
HUMAN;
IMMUNOGENICITY;
MEDICAL DECISION MAKING;
NEUTROPENIA;
ONCOLOGY;
PATENT;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
REVIEW;
BIOLOGICAL AGENTS;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HEMATOLOGY;
HUMANS;
MEDICAL ONCOLOGY;
THERAPEUTIC EQUIVALENCY;
TISSUE DISTRIBUTION;
|
|
EID: 84857897618
PISSN: 17762596
EISSN: 1776260X
Source Type: Journal
DOI: 10.1007/s11523-011-0190-9 Document Type: Review |
|
Times cited : (62)
|
|
References (7)
|
